Roivant Sciences is developing brepocitinib, a new oral drug that blocks both TYK2 and JAK1. These proteins play a key role in autoimmune diseases like dermatomyositis and lupus. Brepocitinib targets several harmful signals in the body, not just one, which may make it more effective than older treatments...
Summary Roche has officially initiated the global rollout of Lunsumio® (mosunetuzumab) for the treatment of adult patients with third-line and beyond relapsed or refractory follicular lymphoma (FL). The fixed-duration, off-the-shelf, T-cell engaging bispecific antibody has already been commercially used in over 2,400 patients, according to company data, with significant adoption across major oncology markets. This move strengthens Roche’s competitive position in hematologic oncology, particularly in indolent lymphomas where unmet need remains high after multiple lines of therapy...
Zomedica Pharmaceuticals has released a new and improved canine cortisol assay for its TRUFORMA point-of-care diagnostic platform. The assay allows veterinarians to diagnose Cushing’s syndrome and Addison’s disease within minutes, using a simple in-clinic process. Previously, such diagnoses required shipping blood samples to external labs and waiting one or two days for results...
Discover the top 5 generative AI tools transforming drug discovery with faster molecule design, target prediction, and real-world pharma applications. Generative AI has almost transformed how drug discovery works today. In the last five years, it has gone from being a research experiment to a practical tool used by biotech firms and pharmaceutical companies around the world...
The market for generic immunology drugs in the Asia-Pacific (APAC) region is witnessing rapid expansion, driven by increasing healthcare access, rising chronic disease prevalence, and cost-containment measures by governments. As more biologics go off-patent, pharma companies are moving quickly to introduce affordable generic and biosimilar alternatives across key APAC markets. If you are planning to enter or expand in this space, pricing is one of the most critical levers for success...
What should a business really look for to know if they’ve hit product-market fit? While businesses often rely on gut feeling or customer praise, that’s not enough. The aim should be to measure product-market fit with real data, not just assumptions. We would look at proven ways to track how well your product is solving a real problem for a real market...
In 2025, the pharmaceutical industry is seeing major changes in drug development, pricing, and delivery. AI is speeding up R&D, GLP-1 drugs are redefining obesity treatment, and precision medicine is becoming standard. This guide breaks down the top trends shaping pharma this year, with real examples and their impact on healthcare and business...
Artificial Intelligence (AI) is changing modern healthcare by helping doctors make faster, smarter decisions. From diagnosing diseases to personalizing treatments and reducing paperwork, AI is making care more accurate and efficient. With the global AI healthcare market expected to reach nearly $96 billion by 2033, it's clear that AI is no longer just a future trend—it’s a key part of today’s medical systems...
AI is changing how we discover new medicines. Instead of testing each idea in a lab, AI studies massive medical data to quickly find the most promising drug candidates. This speeds up research, lowers costs, and improves success rates...
Market research is evolving, and generative AI is at the heart of this transformation. Whether you’re trying to understand customer behavior, test a new product idea, or analyze open-ended feedback, Gen AI can help you do it faster and more efficiently. It doesn’t just crunch numbers; it helps you think, explore, and create...
Several large language models (LLMs) are already being used or evaluated by pharmaceutical companies and health tech teams. From accelerating drug discovery to streamlining regulatory submissions and enhancing patient education, LLMs are redefining how life sciences teams work with data, documents, and decisions. Unlike traditional AI systems, LLMs can read, understand, and generate natural language at scale, making them ideal for navigating the complexity of biomedical literature, clinical protocols, compliance guidelines, and real-world evidence...
Generative AI is helping doctors and scientists design personalized medicine faster and more accurately. These AI tools use medical, genetic, and clinical data to create treatment plans, drugs, and predictions that match an individual’s unique biology. Researchers and biotech companies are now using generative AI (GenAI) models to improve patient care...
AI and ML imaging tools are now central to drug discovery. These systems process cell images to detect drug effects, predict safety, and optimize compounds. In this news article, you will find how AI and ML-based imaging are reshaping drug discovery in 2025...
Regulatory impact assessment (RIA) is an essential step for ensuring pharmaceutical product compliance, quality, and safety whenever changes occur in products or their manufacturing processes. However, this process has traditionally been complex and time-consuming, with risks of delaying product availability and increasing regulatory workload. Today, Generative AI (GenAI) is rapidly changing this landscape, presenting new opportunities for efficiency and accuracy across global pharma operations...
It processes over one thousand interactions per week on cloud infrastructure, making high-precision ligand binding calculations available through a user-friendly interface. How XFEP Works with High‑Precision Physics and AI‑Driven Modeling Physics‑Driven Free Energy Perturbation Enables Accurate Binding Predictions XFEP uses free energy perturbation, a physics‑based method rooted in statistical mechanics, to model how drug molecules bind to target proteins. This method captures the energy difference between bound and unbound states with quantum‑level accuracy...
What should a business really look for to know if they’ve hit product-market fit? While businesses often rely on gut feeling or customer praise, that’s not enough. The aim should be to measure product-market fit with real data, not just assumptions. We would look at proven ways to track how well your product is solving a real problem for a real market...
FHD-909: Pioneering SMARCA2 Inhibition in Oncology – Market Analysis by ConsainsightsFoghorn Therapeutics has announced the development of FHD-909, a first-in-class oral SMARCA2 inhibitor designed to exploit synthetic lethality in cancer driven by SMARCA4 mutations. As a highly selective SMARCA2 inhibitor, FHD-909 stands at the forefront of precision oncology, targeting chromatin remodeling pathways that have been validated as critical vulnerabilities in various tumor types. According to a recent oncology market analysis by Consainsights, FHD-909: Pioneering SMARCA2 Inhibition in Oncology – Market Analysis by Consainsights underscores a multi-billion-dollar market potential, reflecting the growing demand for targeted cancer therapies with robust efficacy and safety profiles.Mechanism of Action and Scientific RationaleFHD-909 operates by selectively inhibiting the ATPase activity of SMARCA2, a key catalytic subunit of the SWI/SNF chromatin remodeling complex...
Pharmaceutical market research helps you make smarter, data-driven decisions across drug development, clinical trials, and market access. It uncovers unmet needs, benchmarks competitors, and guides pricing and positioning—so you reduce risk and increase ROI. Whether you're launching a new therapy or expanding into a new region, this guide shows how to turn real-world insights into strategic advantage...
Why do some beauty brands go viral while others barely make a mark? The answer often lies in market research. Behind every breakout skincare launch or cult-favorite lipstick is a deep understanding of what consumers crave, where gaps exist, and how trends are shifting. If you're in the cosmetics space, guessing won't cut it...
Healthcare market research helps you understand what patients need, how providers operate, and where the market is heading. From rising demand for digital health to shifting care models, it reveals real trends, not guesses. Whether you're launching a new drug, expanding to a new region, or selling to hospitals, research gives you the data to move smartly...
